scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.BBRC.2007.01.180 |
P698 | PubMed publication ID | 17307150 |
P50 | author | Craig M Coopersmith | Q91969671 |
Perry W Grigsby | Q116998139 | ||
Richard S Hotchkiss | Q90459818 | ||
P2093 | author name string | Jonathan E McDunn | |
Kevin W McConnell | |||
Clayton R Hunt | |||
Chris G Davis | |||
Jared T Muenzer | |||
Carolyn A Hilliard | |||
Kathy C Chang | |||
P433 | issue | 2 | |
P921 | main subject | apoptotic process | Q14599311 |
P1104 | number of pages | 7 | |
P304 | page(s) | 501-507 | |
P577 | publication date | 2007-02-08 | |
P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
P1476 | title | Anti-apoptotic peptides protect against radiation-induced cell death | |
P478 | volume | 355 |
Q33789426 | An anti-apoptotic peptide improves survival in lethal total body irradiation |
Q54943530 | BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis. |
Q38957246 | Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease |
Q39277476 | Dying to protect: cell death and the control of T-cell homeostasis. |
Q43419167 | Effects of the TAT peptide orientation and relative location on the protein transduction efficiency |
Q38756877 | Non-canonical roles of Bcl-2 and Bcl-xL proteins: relevance of BH4 domain |
Q36826808 | Nucleophosmin, a critical Bax cofactor in ischemia-induced cell death |
Q37769565 | Radiation victim management and the haematologist in the future: time to revisit therapeutic guidelines? |
Q38887404 | Ryanodine receptors are targeted by anti-apoptotic Bcl-XL involving its BH4 domain and Lys87 from its BH3 domain |
Q30539569 | Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma. |
Q37341230 | Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor. |
Search more.